Christiana DelloRusso

Graham & Walker is an early stage VC fund that identifies and invests in venture capital’s biggest blindspots. We were born from the Female Founders Alliance, the largest community of its kind in the US, and are backed by some of the most influential investors in the country. We live and breathe our values. Our community, founders and LPs are at the heart of everything we do.

N-of-One is a molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results. We provide the highest quality clinical interpretation that dramatically shortens the time from test results to therapeutic strategy options for each case. N-of-One is not a diagnostic laboratory or a bioinformatics company. We exist only to support clinicians in making the best therapeutic decisions.

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.

LRVHealth is the “Inside Healthcare” venture capital platform. LRVHealth’s investors include leading provider, payer, and vendor organizations, comprising a network that touches one in three healthcare consumers across the U.S. Together, this network collaborates to identify, invest in, and adopt innovative solutions to the industry’s most pressing needs. Founded in 2000 by an experienced team of healthcare investors, operators, and advisors, the LRVHealth team provides early stage capital, operating experience, and industry insights to build the next generation of great healthcare companies.

Graham & Walker is an early stage VC fund that identifies and invests in venture capital’s biggest blindspots. We were born from the Female Founders Alliance, the largest community of its kind in the US, and are backed by some of the most influential investors in the country. We live and breathe our values. Our community, founders and LPs are at the heart of everything we do.

Our mission is to provide support to life science entrepreneurs and start-up companies via educational, economic and other resources crucial for their success. Sign up for our weekly newsletter here! http://bit.ly/LSWInewsletter

N-of-One is a molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results. We provide the highest quality clinical interpretation that dramatically shortens the time from test results to therapeutic strategy options for each case. N-of-One is not a diagnostic laboratory or a bioinformatics company. We exist only to support clinicians in making the best therapeutic decisions.

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.